NAMPT and acute coronary syndrome: In this context, enhanced circulating visfatin levels have been recently identified as a novel marker of carotid atherosclerosis in type 2 diabetes mellitus patients [31], while a positive association has also been found between plasma visfatin concentrations and CAD, particularly acute coronary syndromes [32].